Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Castellani paint vs topical timolol for EGFR inhibitor–induced paronychia (intraindividual randomized study)
TCTR20251201009Phase 2Not yet recruiting
- Sponsor
- Sorasak-Napha Lekpreechakul
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in paronychia comparing Castellani paint with Topical timolol (2 arms). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Castellani painttimolol
03
Conditions
paronychia
Beyond the preview
Go deeper on TCTR20251201009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251201009.